Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -1.00K%
March 31, 2026 82.34%
December 31, 2025 95.03%
September 30, 2025 42.67%
June 30, 2025 34.59%
March 31, 2025 26.00%
December 31, 2024 81.90%
September 30, 2024 61.63%
June 30, 2024 52.63%
March 31, 2024 26.71%
December 31, 2023 98.30%
September 30, 2023 56.52%
June 30, 2023 63.76%
March 31, 2023 71.08%
December 31, 2022 69.12%
Date Value
September 30, 2022 64.45%
June 30, 2022 66.88%
March 31, 2022 37.63%
December 31, 2021 90.17%
September 30, 2021 0.00%
June 30, 2021 0.00%
March 31, 2021 0.00%
December 31, 2020 -48.97K%
September 30, 2020 0.00%
June 30, 2020 0.00%
March 31, 2020 0.00%
December 31, 2019 -31.35K%
September 30, 2019 0.00%
June 30, 2019 0.00%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Intellia Therapeutics, Inc. 72.58%
Twist Bioscience Corp. 52.76%
Prime Medicine, Inc. -54.68%
Q32 Bio, Inc. --
Sarepta Therapeutics, Inc. 60.18%

Gross Profit Margin (Quarterly) Related Metrics